For research use only. Not for therapeutic Use.
UL-766(Cat No.:I037816)is an experimental compound under investigation for its potential therapeutic applications in the treatment of autoimmune diseases and cancer. It functions by modulating key signaling pathways involved in immune cell activation and proliferation. Research suggests that UL-766 may inhibit the production of pro-inflammatory cytokines, offering potential in managing conditions like rheumatoid arthritis and lupus. Additionally, it has shown promise in preclinical studies as an adjunct to cancer therapies, potentially enhancing immune system response to tumors.
Catalog Number | I037816 |
Synonyms | Ureter-Label-766; UreterLabel766; Ureter Label 766; Ureter Label-766; UL-766; UL766; UL 766 |
Molecular Formula | C50H73N3O13S2 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | (2E)-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-2-[(2E)-2-[3-[(E)-2-[1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3,3-dimethyl-5-sulfonatoindol-1-ium-2-yl]ethenyl]-2-[3-(trimethylazaniumyl)propoxy]cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethylindole-5-sulfonate |
InChI | InChI=1S/C50H73N3O13S2/c1-49(2)42-36-40(67(54,55)56)16-18-44(42)51(22-26-62-32-34-64-30-28-60-8)46(49)20-14-38-12-10-13-39(48(38)66-25-11-24-53(5,6)7)15-21-47-50(3,4)43-37-41(68(57,58)59)17-19-45(43)52(47)23-27-63-33-35-65-31-29-61-9/h14-21,36-37H,10-13,22-35H2,1-9H3 |
InChIKey | MRAOVJTWSZZVAK-UHFFFAOYSA-N |
SMILES | CC1(C2=C(C=CC(=C2)S(=O)(=O)[O-])[N+](=C1/C=C/C3=C(/C(=C/C=C/4\C(C5=C(N4CCOCCOCCOC)C=CC(=C5)S(=O)(=O)[O-])(C)C)/CCC3)OCCC[N+](C)(C)C)CCOCCOCCOC)C |